Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
NYSE:AMRX 3:59:59 PM EDT
| Market Cap (Intraday) | 750.29M |
| Current PE | 70.54 |
| Forward PE | 8.02 |
| 2yr Forward PE | 7 |
| 10-Day MA | $4.85 |
| 50-Day MA | $4.43 |
| 200-Day MA | $4.36 |
Amneal Pharmaceuticals, Inc. Stock, NYSE:AMRX
400 Crossing Boulevard, Bridgewater, NJ
United States of America
Phone: (908) 947-3120
Number of Employees: 6000
Description
Amneal Pharmaceuticals, Inc., formerly known as Atlas Holdings, Inc. (the "Company"), was formed along with its wholly owned subsidiary, K2 Merger Sub Corporation, a Delaware corporation ("Merger Sub"), on October 4, 2017, for the purpose of facilitating the combination of Impax Laboratories, Inc. (now Impax Laboratories, LLC), a Delaware corporation then listed on the Nasdaq Stock Market ("Impax") and Amneal Pharmaceuticals LLC, a Delaware limited liability company ("Amneal").